This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Safety/Efficacy of Systane Free vs Refresh Tears

This study has been completed.
Information provided by:
Alcon Research Identifier:
First received: June 30, 2006
Last updated: September 23, 2008
Last verified: September 2008
The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Tears Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.

Condition Intervention
Dry Eye Drug: Systane Free Lubricant Eye Drops

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: An Evaluation of the Safety and Efficacy of Systane Free FID 105783 - II

Resource links provided by NLM:

Further study details as provided by Alcon Research:

Primary Outcome Measures:
  • Corneal Staining change from baseline

Secondary Outcome Measures:
  • Comfort, Conjunctival Staining

Estimated Enrollment: 100
Study Start Date: July 2006
Study Completion Date: November 2006
Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • > = 3 stain using NEI grid and need artificial tears at least some of the time.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00348322

United States, Texas
El Paso Facility
El Paso, Texas, United States, 79904
Sponsors and Collaborators
Alcon Research
Study Director: Mike Christensen Alcon Research
  More Information Identifier: NCT00348322     History of Changes
Other Study ID Numbers: C-06-22
Study First Received: June 30, 2006
Last Updated: September 23, 2008

Additional relevant MeSH terms:
Lubricant Eye Drops
Ophthalmic Solutions
Pharmaceutical Solutions processed this record on September 21, 2017